Pharma giant AstraZeneca announces $50B US investment

The company announced on Monday that the British giant of the British giant pharmaceutical preparations is planning Astrazneca to invest $ 50 billion in the United States by 2030.

Astrazneca said it is expected that the investment will create tens of thousands of new and indirect jobs throughout the United States. The “cornerstone” of investment is a new bill of dollars in Virginia that will produce drug materials for the company’s weight management portfolio, which includes oral GLP-1 drugs. Astrazneca said the facility will be the largest individual manufacturing investment in the world.

“Today’s declaration supports our belief in American innovation in vital drugs and our commitment to millions of patients who need our drugs in America and globally,” Pascal Soreut, CEO of Astrazneca, said in a statement. “I look forward to partnership with Governor Youngin and his team to work on the largest investment in individual manufacturing ever. It reflects the Commonwealth desire in Virginia to create highly skilled functions in science and technology, and will enhance the country’s domestic supply chain for medicines.”

Elie Lily invests 27 billion dollars in the United States manufacturing

Investment also includes: expanding the research and development facility in GaeitsBurg, Maryland; Research and Development Center in Kendall Square, Cambridge, Massachusetts; Facilities of manufacturing the following generation to treat cells in Rockeville, Maryland and Tarazana, California; Expand continuous manufacturing in Mount Vernon, Indiana; Coppell manufacturing, Texas; Texas; Texas; New sites to provide clinical trials; Investment in research and development is increasing in new drugs.

“We are proud that Astrazneca has made a decision to produce a large pharmacist to our beaches,” Huard Lottenic Minister Howard Lootnick said in a statement. “This historical investment brings tens of thousands of jobs to the United States and will ensure the production of medicine in our country here.”

Astrazeneca also announced $ 3.5 billion in capital investment in the country, focusing on research, development and manufacturing. The company said it included two billion dollars in the new investment that would create more than 1,000 new highly skills in the United States

Who is investing in America? 23 major companies that promised dollars only under Trump

Part of the investment included a $ 300 million cellular manufacturing factory located in Maryland, which was opened in May. Once it is run, the site will use a relatively new cancer treatment called Car-T cell treatment to help treat blood cancer such as lymphoma and leukemia.

The United States is the largest market in Astrazeneca and represents 42 % of the company’s total revenue. The goal of the drug giant is to increase this number to 50 % by 2030.

Astrazneca hires 18,000 people and supports 92,000 jobs in general in the United States, and currently has 19 research, development, manufacturing and commercial sites in the country.

Astrazeneca logo is out of its headquarters in North America in Willington, Dilayer. (Rachel Wesnovsky photos / Reuters)

The company said that it contributed 5 billion dollars directly to the country’s economy and established about 20 billion dollars in the total value of the American economy.

Get Fox Business on the Go by clicking here

The Monday’s announcement is the latest investment in America under the Trump administration.

Other drug makers, including Bristol Maires Square, Roche, Eli Lily and Johnson & Johnson, have previously announced their intentions to invest billions of dollars in the United States for research, development, manufacturing and factories expansion.